PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma Meeting Abstract

  

Authors:	Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; Yang, C.; Galasso, N.; David, K.; Epstein‐Peterson, Z.; Khan, N.; Kumar, A.; Hamlin, P.; Ghione, P.; Lue, J.; Straus, D.; Zelenetz, A.; Owens, C.; Caron, P.; Intlekofer, A.; Horwitz, S.; Falchi, L.; Johnson, W.; Palomba, M. L.; Noy, A.; Salles, G.; Torka, P.; Vardhana, S.; Yahalom, J.; Dogan, A.; Schoder, H.
Abstract Title:	PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
Meeting Title:	17th International Conference on Malignant Lymphoma (ICML)
Journal Title:	Hematological Oncology
Volume:	41
Issue:	Suppl. 2
Meeting Dates:	2023 Jun 13-17
Meeting Location:	Lugano, Switzerland
ISSN:	0278-0232
Publisher:	Wiley Blackwell
Date Published:	2023-06-01
Start Page:	351
End Page:	353
Language:	English
DOI:	10.1002/hon.3164_253
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164231052&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: 253 -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/207681